RAP 0.00% 20.5¢ raptor resources limited

Ann: Positive Results for Australian Prospective Paediatric Study, page-148

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 2,706 Posts.
    lightbulb Created with Sketch. 504
    Well understood regulatory pathway
    - Held US FDA Pre-Submission meeting in Q1 CY2016, confirmed de novo regulatory pathway strategy
    - FDA submission following US pediatric study completion
    - CE (Europe) and TGA (Australia) submissions following Australian prospective study completion

    That’s Mr Genius to you.....your argument was sorted our back in Q1 2016.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.